Compare Aurora Cannabis Inc (ACB) vs Honeywell International Inc (HON) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

Honeywell Technologies (HON) trades at $225.05, down 2.09% today, following the completion of its aerospace spinoff on June 29, 2026. The stock shows strong fundamentals with a P/E of 18.46 and consistent earnings beats in recent quarters. Technical indicators suggest a bullish trend with support at $225 and resistance at $234. The company maintains solid profitability with 10.89% net margins and 26.41% ROE, though revenue declined slightly to $37.44B in 2025.

The outlook remains positive with 64% analyst buy ratings and a $402.40 consensus price target, representing 79% upside potential. Key risks include integration challenges from recent spinoffs and rising debt-to-asset ratio (46.65% in 2025). The company's focus on high-growth automation segments and ESG alignment provides long-term growth catalysts, though near-term volatility may persist during the post-spinoff transition period.